Enhancing availability of services to control hypertension through a team-based care approach that includes pharmacists.

Autor: Wilson CC, Therrien NL, MacLeod KE, Soloe C, Johnson M, Rivera MD, Jordan J, Shantharam S, Minaya-Junca J, Fulmer EB, Choe HM
Jazyk: angličtina
Zdroj: Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2024 May-Jun; Vol. 64 (3), pp. 102055. Date of Electronic Publication: 2024 Feb 23.
DOI: 10.1016/j.japh.2024.102055
Abstrakt: Background: Primary care physician (PCP) shortages are expected to increase. The Michigan Medicine Hypertension Pharmacists' Program uses a team-based care (TBC) approach to redistribute some patient care responsibilities from PCPs to pharmacists for patients with diagnosed hypertension.
Objective: This evaluation analyzed whether the Michigan Medicine Hypertension Pharmacists' Program increased the availability of hypertension management services and described facilitators that addressed barriers to program sustainability and replicability.
Methods: We conducted a retrospective observational study that used a mixed methods approach. We examined the availability of hypertension management services using the number of pharmacists' referrals of patients to other services and the number of PCP appointments. We analyzed qualitative interviews with program staff and site-level quantitative data to examine the program's impact on the availability of services, the impact of TBC that engaged pharmacists, and program barriers and facilitators.
Results: Patients who visited a pharmacist had fewer PCP visits over 3- and 6-month periods compared to a matched comparison group that did not see a pharmacist and were 1.35 times more likely to receive a referral to a specialist within a 3-month period. Support from leaders and physicians, shared electronic health record access, and financial backing emerged as leading factors for program sustainability and replicability.
Conclusion: Adding pharmacists to the care team reduced the number of PCP appointments per patient while increasing the availability of hypertension management services; this may in turn improve PCPs' availability. Similar models may be sustainable and replicable by relying on organizational buy-in, accessible infrastructure, and financing.
Competing Interests: Disclosure The author declares no relevant conflicts of interest or financial relationships.
(Copyright © 2024 American Pharmacists Association®. All rights reserved.)
Databáze: MEDLINE